Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rhythm Pharmaceuticals Inc (NQ: RYTM ) 46.12 +1.93 (+4.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Rhythm Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Rhythm Pharmaceuticals Announces New Employment Inducement Grants August 13, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire RYTM Stock Earnings: Rhythm Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024 August 06, 2024 RYTM stock results show that Rhythm Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update August 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old July 31, 2024 IMCIVREE now authorized as treatment of obesity and control of hunger in adult patients and pediatric patients 2 years old or older with Bardet Biedl syndrome or POMC, PCSK1, or LEPR deficiency From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 4 Analysts July 25, 2024 Via Benzinga Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity July 23, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 July 23, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces New Employment Inducement Grants July 11, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Analyst Expectations For Rhythm Pharmaceuticals's Future April 26, 2024 Via Benzinga 5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know April 10, 2024 Via Benzinga Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer July 08, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency June 28, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces New Employment Inducement Grants June 11, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024 June 03, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference June 03, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome May 22, 2024 IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centres From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces New Employment Inducement Grants May 09, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire The 3 Best Nasdaq Stocks to Buy in May 2024 May 07, 2024 Although it’s typically the season for selling, shifting market conditions call for the best Nasdaq stocks to buy in May. Via InvestorPlace RYTM Stock Earnings: Rhythm Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 May 07, 2024 RYTM stock results show that Rhythm Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update May 07, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting May 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology April 29, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 April 24, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson April 19, 2024 The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest. Via Benzinga Rhythm Pharmaceuticals Announces New Employment Inducement Grants April 16, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing April 01, 2024 -- Proceeds from financing and existing cash on-hand sufficient to fund planned operations into 2026 -- From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire 7 Stocks That Will Drive the Weight Loss Drugs Market March 28, 2024 The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. Via MarketBeat Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist March 25, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces New Employment Inducement Grants March 11, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences March 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.